Founded in 2015, STR Biotechnologies is a technology-driven biotechnology manufacturer specializing in the design, development, manufacturing, marketing, and global distribution of advanced biomedical and regenerative medicine products. Bringing together engineering excellence and medical expertise, the company is committed to delivering innovative, high-quality, and user-friendly healthcare solutions to professionals worldwide.

​

Since its establishment, STR Biotechnologies has continuously expanded its product portfolio to meet the evolving needs of regenerative medicine and biological therapies. Today, the company develops and manufactures a wide range of technologies, including PRP, PRF, CGF, SVF, Bone Marrow Concentration (BMAC), Platelet-Derived Exosome Systems, Cytokine and Interleukin Therapies, Ozone Therapy Solutions, Laboratory Equipment, and Advanced Centrifuge Technologies.

​

Under its internationally recognized brands, STR Biotechnologies offers innovative solutions such as HighCell®, Unique®, S&M® PRP Systems, GrowthCell® CGF Technology, LIPOSTEM® SVF Kit, STEMMEX® Bone Marrow Kit, ExoPrime® Exosome Technology, STRAKIN® Cytokine Therapy System, Renewa Capilla® Fibroblast Technology, STRozone® Ozone Therapy Systems, and LABFUGE® Regenerative Medicine Centrifuges.

​

Driven by a culture of continuous improvement, STR Biotechnologies integrates scientific research, engineering innovation, manufacturing expertise, and customer feedback into every stage of product development. This approach enables the company to consistently enhance product performance, reliability, and clinical value while maintaining the highest standards of quality and user satisfaction.

Operating from its modern manufacturing facilities, STR Biotechnologies follows international quality standards and regulatory requirements, supporting healthcare professionals, clinics, distributors, and medical brands worldwide through flexible OEM and Private Label manufacturing solutions.

​

Today, STR Biotechnologies continues to invest in innovation, scientific advancement, and next-generation regenerative medicine technologies, with the vision of becoming a globally recognized leader in biotechnology and medical device manufacturing.